Literature DB >> 20644152

A hereditary moyamoya syndrome with multisystemic manifestations.

D Hervé1, P Touraine, A Verloes, S Miskinyte, V Krivosic, D Logeart, N Alili, J D Laredo, A Gaudric, E Houdart, J P Metzger, E Tournier-Lasserve, F Woimant.   

Abstract

OBJECTIVE: We report a detailed description of a family affected by a hereditary multisystem disorder associated with moyamoya syndrome.
METHODS: In this family case report, we evaluated 9 members of the same family originating from Algeria. Investigations included neuroimaging, cardiologic and ophthalmologic evaluation, hormonal testing, hemoglobin electrophoresis, chromosomal karyotyping, muscle biopsy for morphology, immunohistochemistry and enzyme assays, mtDNA mutation screening, and haplotype analysis of 2 loci previously linked to moyamoya, on chromosomes 10 (ACTA2) and 17.
RESULTS: Five males related through a maternal lineage were affected, suggesting an X-linked inheritance. Four of them had symptomatic moyamoya syndrome with an onset of acute neurologic manifestations between 4 and 32 years. Hypergonadotropic hypogonadism, azoospermia, short stature of postnatal onset (-2 to -4 SD in adulthood), premature graying of hair, and dysmorphism were present in all patients. The other features of the disease included early cataract in 4, dilated cardiomyopathy in 3, and partial growth hormone deficiency in 2 members. Muscle biopsy data did not reveal signs of a mitochondrial disorder. All conditions known to be associated with moyamoya syndrome such as Down syndrome, neurofibromatosis, and sickle cell disease were excluded. We also excluded linkage to the 2 loci previously reported to be involved in autosomal dominant syndromic and nonsyndromic moyamoya. Carrier females had normal phenotype and clinical history.
CONCLUSIONS: These data strongly suggest that this family is affected by a hereditary moyamoya multisystem disorder with X-linked recessive pattern of inheritance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644152     DOI: 10.1212/WNL.0b013e3181e8ee3f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

2.  Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.

Authors:  Anthony S Larson; Luis Savastano; James Klaas; Giuseppe Lanzino
Journal:  Neurosurg Rev       Date:  2020-06-07       Impact factor: 3.042

3.  A contiguous microdeletion syndrome at Xp23.13 with non-obstructive azoospermia and congenital cataracts.

Authors:  Aubrey Milunsky; Jeff M Milunsky; Weilai Dong; Hayk Hovhannisyan; Robert D Oates
Journal:  J Assist Reprod Genet       Date:  2020-01-09       Impact factor: 3.412

Review 4.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

5.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.

Authors:  Snaigune Miskinyte; Matthew G Butler; Dominique Hervé; Catherine Sarret; Marc Nicolino; Jacob D Petralia; Francoise Bergametti; Minh Arnould; Van N Pham; Aniket V Gore; Konstantinos Spengos; Steven Gazal; France Woimant; Gary K Steinberg; Brant M Weinstein; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2011-05-19       Impact factor: 11.025

Review 6.  Genetic susceptibility to cerebrovascular disease.

Authors:  David Della-Morte; Francesca Pacifici; Tatjana Rundek
Journal:  Curr Opin Lipidol       Date:  2016-04       Impact factor: 4.776

7.  An autosomal recessive leucoencephalopathy with ischemic stroke, dysmorphic syndrome and retinitis pigmentosa maps to chromosome 17q24.2-25.3.

Authors:  Ahmed Bouhouche; Ali Benomar; Leila Errguig; Lamiae Lachhab; Naima Bouslam; Jehanne Aasfara; Sanaa Sefiani; Layachi Chabraoui; Elmostafa El Fahime; Abdeljalil El Quessar; Mohamed Jiddane; Mohamed Yahyaoui
Journal:  BMC Med Genet       Date:  2012-03-21       Impact factor: 2.103

Review 8.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

9.  Molecular Mechanisms of Syndromic Cryptorchidism: Data Synthesis of 50 Studies and Visualization of Gene-Disease Network.

Authors:  Kristian Urh; Živa Kolenc; Maj Hrovat; Luka Svet; Peter Dovč; Tanja Kunej
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-26       Impact factor: 5.555

10.  A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How.

Authors:  Xiaoli Si; Lingfei Li; Yuanjian Fang; Yaping Yan; Jiali Pu
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.